Citations

Citations to this article as recorded by  

• Association Study of Pleural Mesothelioma and Oncogenic Simian Virus 40 in the Crocidolite-Contaminated Area of Dayao County, Yunnan Province, Southwest China
  Ru-ai Liu, Bo-yong Wang, Xin Chen, Yuan-qian Pu, Jia-ji Zi, Wen Mei, Ye-pin Zhang, Lu Qiu, Wei Xiong
  Genetic Testing and Molecular Biomarkers.2024;[Epub]     CrossRef
• Binding of SV40’s Viral Capsid Protein VP1 to Its Glycosphingolipid Receptor GM1 Induces Negative Membrane Curvature: A Molecular Dynamics Study
  Raisa Kociurzynski, Sophie D. Beck, Jean-Baptiste Bouhon, Winfried Römer, Volker Knecht
  Langmuir.2019; 35(9): 3534.     CrossRef
• Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033
  Kyeong Min Kwak, Domyung Paek, Seung-sik Hwang, Young-Su Ju, Mark Allen Pershouse
  PLOS ONE.2017; 12(8): e0183404.     CrossRef
• The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms
  Leonardo Vinícius Monteiro de Assis, Mauro César Isoldi
  Tumor Biology.2014; 35(2): 889.     CrossRef
• The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma
  Leonardo Vinícius Monteiro de Assis, Jamille Locatelli, Mauro César Isoldi
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2014; 1845(2): 232.     CrossRef
• Pleural Mesothelioma: An Institutional Experience of 66 Cases
  Soomin Ahn, In Ho Choi, Joungho Han, Jhingook Kim, Myung-Ju Ahn
  Korean Journal of Pathology.2014; 48(2): 91.     CrossRef

Mutations of the epidermal growth factor receptor (EGFR) are the strongest predictive factor for response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib. EGFR TKIs are approved in Korea as a first-line treatment for lung cancer patients with mutated EGFR. Rapid and accurate EGFR mutation testing is essential for patient selection and establishing targeted therapies with EGFR TKIs. Thus, a standard set of guideline recommendations for EGFR mutation testing suitable for the Korean medical community is necessary. In this article, we propose a set of guideline recommendations for EGFR mutation testing that was discussed and approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists.

Citations

Citations to this article as recorded by  

• Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
  Insu Kim, Hee Yun Seol, Soo Han Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop Eom
  Cancers.2023; 15(5): 1445.     CrossRef
• Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
  Dorine de Jong, Jeeban P. Das, Hong Ma, Jacienta Pailey Valiplackal, Conor Prendergast, Tina Roa, Brian Braumuller, Aileen Deng, Laurent Dercle, Randy Yeh, Mary M. Salvatore, Kathleen M. Capaccione
  Cancers.2023; 15(10): 2855.     CrossRef
• Coordination games in cancer
  Péter Bayer, Robert A. Gatenby, Patricia H. McDonald, Derek R. Duckett, Kateřina Staňková, Joel S. Brown, Jun Tanimoto
  PLOS ONE.2022; 17(1): e0261578.     CrossRef
• Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
  Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
  Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
• Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy
  Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Han W Tun
  Journal of Blood Medicine.2021; Volume 12: 833.     CrossRef
• Molecular Testing of Lung Cancers
  Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee
  Journal of Pathology and Translational Medicine.2017; 51(3): 242.     CrossRef
• Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience
  Choonhee Son, Eun‐Ju Kang, Mee Sook Roh
  Diagnostic Cytopathology.2015; 43(7): 532.     CrossRef
• Ultrasonography-Guided Core Biopsy of Supraclavicular Lymph Nodes for Diagnosis of Metastasis and Identification of Epidermal Growth Factor Receptor (EGFR) Mutation in Advanced Lung Cancer
  Jooae Choe, Mi Young Kim, Jung Hwan Baek, Chang-Min Choi, Hwa Jung Kim
  Medicine.2015; 94(29): e1209.     CrossRef
• Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non‐small‐cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage
  Tae‐Jung Kim, Chan Kwon Park, Chang Dong Yeo, Kihoon Park, Chin Kook Rhee, Jusang Kim, Seung Joon Kim, Sang Haak Lee, Kyo‐Young Lee, Hyoung‐Kyu Yoon
  Journal of Surgical Oncology.2014; 110(3): 245.     CrossRef
• Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry
  An Na Seo, Tae-In Park, Yan Jin, Ping-Li Sun, Hyojin Kim, Hyun Chang, Jin-Haeng Chung
  Lung Cancer.2014; 83(3): 316.     CrossRef
• Molecular Pathology of Lung Cancer: Current Status and Future Directions
  Mee Sook Roh
  Tuberculosis and Respiratory Diseases.2014; 77(2): 49.     CrossRef

Primary thymic mucinous adenocarcinoma is an extremely rare aggressive subtype of thymic carcinoma. With a review of literatures, only nine cases have been reported up to present. A 36-year-old woman was admitted for further evaluation and treatment of a mediastinal mass. The patient had no medical history of cancer. The clinicoradiological examination disclosed no tumor elsewhere. After the surgical excision of mediastinal mass, it was grossly a round semi-solid mass with mucin-filled cystic areas. Microscopically solid areas showed cords, small nests and dilated glands infiltrating the fibrotic parenchyma, while the cystic areas were lined by mucinous epithelium with tumor cells floating in extracellular-mucin pools. Some cystic walls underwent malignant transformation of the benign thymic epithelium. Immunohistochemically, the tumor cells were positive for cytokeratin (CK) 7, CK20, CD5, and CDX-2, and negative for thyroid transcription factor-1. In conclusion, the mucinous thymic adenocarcinoma should be recognized as a separate histopathological entity and considered in the differential diagnosis of mediastinal carcinomas.

Citations

Citations to this article as recorded by  

• Stage IV thymic mucinous adenocarcinoma under long-term disease control after primary tumor resection: A case report
  Chihaya Maeda, Tomoyuki Hishida, Kyohei Masai, Keisuke Asakura, Katsura Emoto, Hisao Asamura
  The Journal of the Japanese Association for Chest Surgery.2022; 36(2): 156.     CrossRef
• Lenvatinib-refractory thymic mucinous carcinoma with PIK3CA mutation
  Akihiro Tsukaguchi, Shoichi Ihara, Hironao Yasuoka, Seigo Minami
  International Cancer Conference Journal.2022; 12(1): 36.     CrossRef
• Thymic mucinous adenocarcinoma: A case report
  Hideki Tsubouchi, Naoki Ozeki, Yuka Suzuki, Koji Kawaguchi, Takayuki Fukui, Toyofumi F. Chen-Yoshikawa
  The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 547.     CrossRef
• Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report
  Man Li, Xiao-Yu Pu, Li-Hua Dong, Peng-Yu Chang
  World Journal of Clinical Cases.2021; 9(7): 1676.     CrossRef
• Primary Mucinous Adenocarcinoma of the Thymus: a Rare Type of Thymic Carcinoma—Case Report
  Koichi Tomoshige, Tomoshi Tsuchiya, Keitaro Matsumoto, Takuro Miyazaki, Ryoichiro Doi, Ryusuke Machino, Satoshi Mizoguchi, Takamune Matumoto, Yutaka Maeda, Takeshi Nagayasu
  SN Comprehensive Clinical Medicine.2021; 3(5): 1233.     CrossRef
• Primary mucinous adenocarcinoma of the thymus: A case report
  Tomoka Hamahiro, Ryo Maeda, Takanori Ayabe, Yuichiro Sato, Masaki Tomita
  Respiratory Medicine Case Reports.2021; 34: 101497.     CrossRef
• Primary Thymic Mucinous Adenocarcinoma: A Case Report Focusing on Radiological Findings and Review of the Literature
  Young Hoon Koo, Jae Wook Lee, Jai Soung Park, Kyung Eun Shin, Heon Lee, Susie Chin
  Iranian Journal of Radiology.2020;[Epub]     CrossRef
• Mucinous adenocarcinoma of the thymus: report of a case
  Fumihiko Kinoshita, Fumihiro Shoji, Kazuki Takada, Gouji Toyokawa, Tatsuro Okamoto, Tokujiro Yano, Yoshinao Oda, Yoshihiko Maehara
  General Thoracic and Cardiovascular Surgery.2018; 66(2): 111.     CrossRef
• Thymic enteric type adenocarcinoma: A case report with cytological features
  Marie Tamai, Mitsuaki Ishida, Yusuke Ebisu, Hisashi Okamoto, Chika Miyasaka, Chisato Ohe, Yoshiko Uemura, Tomohito Saito, Tomohiro Murakawa, Koji Tsuta
  Diagnostic Cytopathology.2018; 46(1): 92.     CrossRef
• Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation
  Neda Kalhor, Cesar A. Moran
  Human Pathology.2018; 74: 73.     CrossRef
• Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature
  Ah-Young Kwon, Joungho Han, Jinah Chu, Yong Soo Choi, Byeong-Ho Jeong, Myung-Ju Ahn, Yong Chan Ahn
  Pathology - Research and Practice.2017; 213(2): 106.     CrossRef
• Cytologic Characteristics of Thymic Adenocarcinoma with Enteric Differentiation: A Study of Four Fine-Needle Aspiration Specimens
  Ah-Young Kwon, Joungho Han, Hae-yon Cho, Seokhwi Kim, Heejin Bang, Jiyeon Hyeon
  Journal of Pathology and Translational Medicine.2017; 51(5): 509.     CrossRef
• Mucinous cystic tumor with CK20 and CDX2 expression of the thymus: Is this a benign counterpart of adenocarcinoma of the thymus, enteric type?
  Jun Akiba, Hiroshi Harada, Shintaro Yokoyama, Toshihiro Hashiguchi, Akihiko Kawahara, Masahiro Mitsuoka, Shinzo Takamori, Hirohisa Yano
  Pathology International.2016; 66(1): 29.     CrossRef
• Colon cancer chemotherapy for a patient with CDX2-expressing metastatic thymic adenocarcinoma: a case report and literature review
  Akihiko Sawaki, Mikiya Ishihara, Yuji Kozuka, Hiroyasu Oda, Satoshi Tamaru, Yumiko Sugawara, Yoshiki Yamashita, Toshiro Mizuno, Taizo Shiraishi, Naoyuki Katayama
  International Cancer Conference Journal.2016; 5(2): 113.     CrossRef
• Adenocarcinoma of the Thymus, Enteric Type
  Bernhard Moser, Ana Iris Schiefer, Stefan Janik, Alexander Marx, Helmut Prosch, Wolfgang Pohl, Barbara Neudert, Anke Scharrer, Walter Klepetko, Leonhard Müllauer
  American Journal of Surgical Pathology.2015; 39(4): 541.     CrossRef
• A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
  Eun Na Cho, Hye Sung Park, Tae Hoon Kim, Min Kwang Byun, Hyung Jung Kim, Chul Min Ahn, Yoon Soo Chang
  Tuberculosis and Respiratory Diseases.2015; 78(2): 112.     CrossRef
• A Rare Case of Primary Tubular Adenocarcinoma of the Thymus, Enteric Immunophenotype: A Case Study and Review of the Literature
  Hae Yoen Jung, Hyundeuk Cho, Jin-Haeng Chung, Sang Byoung Bae, Ji-Hye Lee, Hyun Ju Lee, Si-Hyong Jang, Mee-Hye Oh
  Journal of Pathology and Translational Medicine.2015; 49(4): 331.     CrossRef
• Primary mucinous adenocarcinoma of the thymus: a case report
  Tadashi Sakane, Kotaro Mizuno, Risa Oda, Takuya Matsui, Makoto Ito, Takeshi Yamada
  The Journal of the Japanese Association for Chest Surgery.2014; 28(7): 904.     CrossRef